Back
Theravance Biopharma, Inc. 10K Form
Sell
44
TBPH
Theravance Biopharma, Inc.
Last Price:
$18.71
Seasonality Move:
7.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TBPH News And Ratings
See the #1 stock for the next 7 days that we like better than TBPH
TBPH Financial Statistics
Sales & Book Value
| Annual Sales: | $64.4M |
|---|---|
| Cash Flow: | $-6.5M |
| Price / Cash Flow: | 3.87 |
| Annual Sales: | $4.59 |
| Price / Book: | 4.07 |
Profitability
| EPS (TTM): | 0.56250 |
|---|---|
| Net Income (TTM): | $29.3M |
| Gross Margin: | $58.4M |
| Return on Equity: | 14.9% |
| Return on Assets: | 7.74% |
Theravance Biopharma, Inc. Earnings Forecast
Key Theravance Biopharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 14 years for TBPH is 90.66%.
-
The Selling, General & Administrative Expenses for TBPH have been equal to 107.44% of Gross Profit Margin.
-
The Research & Development expenses have been 55.98% of Revenue.
-
The Net Earning history of TBPH is -87.63% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 6 years.
Theravance Biopharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TBPH |
| CUSIP: | G8807B |
| Website: | theravance.com |
Debt
| Debt-to-Equity Ratio: | 0.19 |
|---|---|
| Current Ratio: | 9.48 |
| Quick Ratio: | 9.3 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 12.55 |
TBPH Technical Analysis vs Fundamental Analysis
Sell
44
Theravance Biopharma, Inc. (TBPH)
is a Sell
Is Theravance Biopharma, Inc. a Buy or a Sell?
-
Theravance Biopharma, Inc. stock is rated a SellThe current Theravance Biopharma, Inc. [TBPH] share price is $18.70. The Score for TBPH is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.